| Title |
Author |
Type |
Date |
Words |
| United States : Janssen Submits New Drug Application to U.S. FDA for Apalutamide (ARN-509) to Treat Men with Non-Metastatic Castration-Resistant Prostate Cancer. |
|
|
Oct 12, 2017 |
394 |
| Janssen Biotech submits NDA with the US FDA for apalutamide for non-metastatic castration-resistant prostate cancer. |
|
|
Oct 12, 2017 |
240 |
| Janssen Biotech submits NDA with the US FDA for apalutamide for non-metastatic castration-resistant prostate cancer. |
|
|
Oct 12, 2017 |
244 |
| Janssen Submits New Drug Application to U.S. FDA for Apalutamide (ARN-509) to Treat Men with Non-Metastatic Castration-Resistant Prostate Cancer. |
|
|
Oct 11, 2017 |
1322 |
| Astellas and Seattle Genetics Initiate Pivotal Trial of Enfortumab Vedotin for Patients with Locally Advanced or Metastatic Urothelial Cancer. |
|
|
Oct 10, 2017 |
1310 |
| Susan G. Komen Launches Its First Crowdfunding Initiative To Support Metastatic Breast Cancer Research. |
|
|
Oct 3, 2017 |
1003 |
| Adding radiation to chemotherapy may dramatically improve survival for advanced-stage NSCLC patients. |
|
|
Sep 24, 2017 |
1909 |
| Germany : European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma. |
|
|
Sep 22, 2017 |
713 |
| European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma. |
|
|
Sep 21, 2017 |
4362 |
| Oncolytics Biotech[R] Announces Successful End-of-Phase 2 Meeting with FDA for REOLYSIN[R] in Metastatic Breast Cancer. |
|
|
Sep 18, 2017 |
917 |
| Janssen submits supplemental NDA to US FDA for ZYTIGA for metastatic prostate cancer based on data from LATITUDE trial. |
|
|
Sep 15, 2017 |
320 |
| Janssen submits supplemental NDA to US FDA for ZYTIGA for metastatic prostate cancer based on data from LATITUDE trial. |
|
|
Sep 15, 2017 |
316 |
| United States : Pfizer and Astellas Announce Positive Top-Line Results from Phase 3 PROSPER Trial of XTANDI (enzalutamide) in Patients with Non-Metastatic Castration-Resistant Prostate Cancer. |
|
|
Sep 15, 2017 |
475 |
| Pfizer and Astellas Announce Positive Top-Line Results from Phase 3 PROSPER Trial of XTANDI (enzalutamide) in Patients with Non-Metastatic Castration-Resistant Prostate Cancer. |
|
|
Sep 14, 2017 |
2884 |
| Data from Pfizer Study of Trastuzumab Biosimilar Demonstrates Equivalence in ORR for Patients with HER2-positive Metastatic Breast Cancer. |
|
Clinical report |
Sep 12, 2017 |
319 |
| United States : Lilly Builds Upon Body of Clinical Evidence for CYRAMZA (ramucirumab) with Phase 3 RANGE Data Demonstrating Superior Progression-Free Survival in Advanced or Metastatic Urothelial Cancer. |
|
Clinical report |
Sep 11, 2017 |
486 |
| Novartis Phase III study demonstrates adjuvant Tafinlar + Mekinist reduced the risk of disease recurrence by 53% in patients with resected BRAF V600 mutation-positive melanoma. |
|
|
Sep 10, 2017 |
3804 |
| United States : CheckMate -214 Study Evaluating Opdivo in Combination with Yervoy Stopped Early for Demonstrating Overall Survival Benefit in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma. |
|
|
Sep 8, 2017 |
200 |
| Thermal Ablation in the Management of Adrenal Metastasis Originating from Non-small Cell Lung Cancer: A 5-year Single-center Experience. |
Botsa, Evanthia; Thanou, Ioanna; Papatheodoropoulou, Aspasia; Thanos, Loukas |
Report |
Sep 1, 2017 |
3228 |
| FDA Grants Breakthrough Therapy Designation to Daiichi Sankyo's DS-8201 for HER2-Positive Metastatic Breast Cancer. |
|
|
Aug 29, 2017 |
1202 |
| Daiichi Sankyo Initiates Pivotal Phase 2 Study of DS-8201 in Patients with HER2-Positive Metastatic Breast Cancer. |
|
|
Aug 29, 2017 |
1234 |
| The Alliance Foundation Trials launches PATINA trial for metastatic breast cancer. |
|
|
Aug 24, 2017 |
235 |
| The Alliance Foundation Trials launches PATINA trial for metastatic breast cancer. |
|
|
Aug 24, 2017 |
231 |
| Immune therapy durable in melanoma brain metastases. |
Oakes, Kari |
Clinical report |
Aug 1, 2017 |
773 |
| Ocular metastasis as initial presentation in breast cancer. |
Maliepaard, M.; Mesham, M.; Aleksic, Z.; Scholtz, R.; Edge, J. |
Clinical report |
Aug 1, 2017 |
1572 |
| Astrazeneca's Phase III FLAURA trial shows strong result for Tagrisso in lung cancer. |
|
|
Jul 28, 2017 |
273 |
| Astrazeneca's Phase III FLAURA trial shows strong result for Tagrisso in lung cancer. |
|
|
Jul 28, 2017 |
277 |
| Germany,United States : EMAs CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma. |
|
|
Jul 22, 2017 |
592 |
| EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma. |
|
|
Jul 21, 2017 |
4050 |
| CTC4BMP: Circulating tumor cells for tailoring BMP targeted therapies. |
|
|
Jul 7, 2017 |
234 |
| New Analysis Reveals First-Line Treatment Data on SIR-Spheres Y-90 Resin Microspheres for Patients with Liver Metastases from Right-Sided Primary Colon Cancer. |
|
|
Jul 3, 2017 |
2390 |
| New Analysis Reveals First-Line Treatment Data on SIR-Spheres Y-90 Resin Microspheres for Patients with Liver Metastases from Right-Sided Primary Colon Cancer. |
|
|
Jul 3, 2017 |
2396 |
| Predictive value of stathmin-1 and osteopontin expression for taxan resistance in metastatic castrate-resistant prostate cancer. |
|
Report |
Jun 30, 2017 |
3527 |
| IsoRay Announces Study Published in The International Journal of Radiation Oncology, Biology, Physics entitled, "Clinical Outcomes of Large Brain Metastases Treated with Neurosurgical Resection and Intraoperative Cesium-131 Brachytherapy: Results of a Prospective Trial". |
|
|
Jun 20, 2017 |
889 |
| United States : Astellas and Pfizer Announce Amendment to Clinical Research Protocol for Phase 3 PROSPER Trial of enzalutamide in Patients with Non-metastatic Castration-Resistant Prostate Cancer. |
|
Clinical report |
Jun 10, 2017 |
337 |
| Astellas and Pfizer Announce Amendment to Clinical Research Protocol for Phase 3 PROSPER Trial of enzalutamide in Patients with Non-metastatic Castration-Resistant Prostate Cancer. |
|
Clinical report |
Jun 9, 2017 |
2325 |
| Q BioMed Inc Announces Commercialization of Non-Narcotic Metastatic Cancer Pain Drug. |
|
|
Jun 7, 2017 |
1250 |
| United States : Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Demonstrated Promising Activity in Previously Treated Patients with dMMR or MSI-H Metastatic Colorectal Cancer in Phase 2 CheckMate -142 Study. |
|
|
Jun 5, 2017 |
433 |
| United States : Lynparza significantly reduces the risk of disease worsening or death in patients with BRCA-mutated metastatic breast cancer. |
|
|
Jun 5, 2017 |
520 |
| Blueprint Medicines Announces New Phase 1 Clinical Data for BLU-285 in Advanced Gastrointestinal Stromal Tumors and Plans to Pursue Expedited Development in Patients with a PDGFR[eth] D842V Mutation. |
|
|
Jun 5, 2017 |
3266 |
| Astellas and Seattle Genetics Announce Updated Enfortumab Vedotin Phase 1 Data in Metastatic Urothelial Cancer at 2017 ASCO Annual Meeting. |
|
|
Jun 5, 2017 |
1720 |
| Abiraterone Acetate Provided Significant Clinical Benefit in Patients with High-Risk Metastatic Hormone-NaE[macron]ve Prostate Cancer (mHNPC), Improving Overall Survival and Radiographic Progression-Free Survival. |
|
|
Jun 3, 2017 |
2922 |
| Cancer. |
|
|
Jun 1, 2017 |
167 |
| Liver transplantation for non-resectable colorectal liver metastases at a single centre in South Africa: a report of the ethics and regulatory approval process. |
Etheredge, H.R.; Botha, J.; Cleaton-Jones, P. |
Report |
Jun 1, 2017 |
1775 |
| New research in kidney cancer, ASCO-GU 2017. |
Basappa, Naveen; Pouliot, Frederic |
|
Jun 1, 2017 |
1491 |
| Lilly Announces Phase 3 RANGE Urothelial Cancer Trial of CYRAMZA (ramucirumab) Met Primary Endpoint, Improving Progression-Free Survival. |
|
Clinical report |
May 31, 2017 |
4616 |
| Innovative Patient Registry to Provide Important Insights into the "Real World" Management of Metastatic Colorectal Cancer. |
|
Disease/Disorder overview |
May 30, 2017 |
739 |
| Metastatic Colorectal Cancer Patients Treated First-line With SIR-Spheres Y-90 Resin Microspheres More Likely to Become Candidates for Potentially Curative Liver Surgery, REsect Study Shows. |
|
|
May 24, 2017 |
1095 |
| Metastatic Colorectal Cancer Patients Treated First-line With SIR-Spheres Y-90 Resin Microspheres More Likely to Become Candidates for Potentially Curative Liver Surgery, REsect Study Shows. |
|
|
May 24, 2017 |
1101 |
| Pigmented skin lesions lightened during immunotherapy. |
Smith, Jennie |
|
May 1, 2017 |
363 |
| QUAD SHOT - HYPOFRACTIONATED RADIOTHERAPY FOR PALLIATION IN ADVANCED SQUAMOUS CELL CARCINOMA OF HEAD AND NECK. |
|
Report |
Apr 30, 2017 |
1947 |
| Expression of CD133, E-cadherin and WWOX in colorectal cancer and related analysis. |
|
|
Apr 30, 2017 |
2845 |
| United States : Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval of Opdivo (nivolumab) for the Treatment of Patients with Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma, a Type of Bladder Cancer. |
|
|
Apr 25, 2017 |
829 |
| AbbVie Announces Topline Results from Two Phase 3 Studies Investigating Veliparib in Combination with Chemotherapy for the Treatment of Patients with Advanced or Metastatic Squamous Non-Small Cell Lung Cancer and Early-Stage Triple-Negative Breast Cancer. |
|
|
Apr 19, 2017 |
1207 |
| AUA, ASCO, ASTRO and SUO Announce New Practice Guideline For Treatment Of Non-Metastatic Muscle-Invasive Bladder Cancer. |
|
|
Apr 13, 2017 |
507 |
| Bristol-Myers Squibb submits sBLA with US FDA to extend the use of Opdivo in patients with dMMR or MSI-H metastatic colorectal cancer. |
|
|
Apr 5, 2017 |
270 |
| Bristol-Myers Squibb submits sBLA with US FDA to extend the use of Opdivo in patients with dMMR or MSI-H metastatic colorectal cancer. |
|
|
Apr 5, 2017 |
266 |
| NICE recommends Merck's Erbitux for patients with metastatic colorectal cancer. |
|
|
Mar 3, 2017 |
216 |
| NICE recommends Merck's Erbitux for patients with metastatic colorectal cancer. |
|
|
Mar 3, 2017 |
212 |
| Metastatic thymoma in a scarlet macaw (Ara macao). |
Lang, Barbara; Vorbruggen, Susanne; Kothe, Ruth; Britsch, Gerd; Schmidt, Volker |
Report |
Mar 1, 2017 |
3245 |
| EMD Serono's BLA for avelumab accepted by US FDA for the treatment of patients with locally advanced or metastatic urothelial carcinoma. |
|
|
Mar 1, 2017 |
290 |
| EMD Serono's BLA for avelumab accepted by US FDA for the treatment of patients with locally advanced or metastatic urothelial carcinoma. |
|
|
Mar 1, 2017 |
286 |
| Rexahn Pharmaceuticals begins treatment under Phase IIa trial of Supinoxin in metastatic TNBC negative breast cancer patients. |
|
Clinical report |
Feb 24, 2017 |
277 |
| Rexahn Pharmaceuticals begins treatment under Phase IIa trial of Supinoxin in metastatic TNBC negative breast cancer patients. |
|
Clinical report |
Feb 24, 2017 |
273 |
| Novartis drug Zykadia granted FDA Priority Review. |
|
|
Feb 24, 2017 |
256 |
| Novartis drug Zykadia granted FDA Priority Review. |
|
|
Feb 24, 2017 |
252 |
| FDA Accepts Two sBLAs for US Merck's Keytruda for Locally Advanced or Metastatic Urothelial Cancer. |
|
|
Feb 3, 2017 |
473 |
| EC Approves US Merck's Keytruda for First-Line Treatment of Metastatic Non-Small Cell Lung Cancer When Tumors Have High PD-L1 Expression with No EGFR or ALK Positive Tumor Mutations. |
|
|
Feb 1, 2017 |
332 |
| Agilent Technologies Expands Dako PD-L1 IHC 22C3 PharmDx Companion Diagnostics. |
|
|
Feb 1, 2017 |
371 |
| Adenocarcinoma of the cecum with rare splenic metastasis. |
Lucke-Wold, Brandon; Bonasso, Patrick C.; Turner, Ryan; Cassim, Riaz |
Clinical report |
Jan 1, 2017 |
1645 |
| Prognostic significance of B7-H3 expression in patients with colorectal cancer: A meta-analysis. |
|
|
Dec 31, 2016 |
3904 |
| Merck receives positive recommendation for KEYTRUDA for treating metastatic non-small cell lung cancer in adults. |
|
|
Dec 19, 2016 |
311 |
| Merck receives positive recommendation for KEYTRUDA for treating metastatic non-small cell lung cancer in adults. |
|
|
Dec 19, 2016 |
307 |
| CA thyroid with metastases. |
Kumar, Shishir; Chitnis, Ashuthosh; Kapoor, Priti; Palve, Rini; Vijay, Meeta |
Clinical report |
Dec 12, 2016 |
905 |
| United States : PALOMA-2 Phase 3 Study Published in The New England Journal Of Medicine Demonstrates Clinical Benefit Of Pfizers IBRANCE (palbociclib) In First-Line ER+, HER2- Metastatic Breast Cancer. |
|
|
Nov 17, 2016 |
363 |
| Eisai Welcomes Positive NICE recommendation for Halaven (eribulin) for Patients with Locally Advanced or Metastatic Breast Cancer. |
|
|
Nov 2, 2016 |
1350 |
| Impact of active smoking on survival of patients with metastatic lung adenocarcinoma harboring an epidermal growth factor receptor (EGFR) mutation. |
Erdogan, Bulent; Kodaz, Hilmi; Karabulut, Senem; Cinkaya, Ahmet; Tozkir, Hilmi; Tanriverdi, Ozgur; C |
|
Nov 1, 2016 |
4384 |
| Celldex Therapeutics achieved positive results from a Phase II study of glembatumumab vedotin in patients with stage III/IV checkpoint inhibitor-refractory, and, if applicable, BRAF/MEK inhibitor-refractory metastatic melanoma (n=62). |
|
Clinical report |
Nov 1, 2016 |
268 |
| OncoGenex Announces Positive Survival Results from Apatorsen Phase 2 Borealis-2(TM) Trial in Metastatic Bladder Cancer. |
|
Financial report |
Oct 25, 2016 |
923 |
| First Patient in Malaysia Receives TheraSphere(TM) radioembolisation Therapy. |
|
|
Oct 19, 2016 |
1328 |
| First Patient in Malaysia Receives TheraSphere(TM) radioembolisation Therapy. |
|
|
Oct 19, 2016 |
1333 |
| Review Of Delcath's CHEMOSAT Accepted For Publication In Advances In Therapy. |
|
|
Oct 17, 2016 |
937 |
| Delcath Announces First European Clinical Sites For FOCUS Phase 3 Trial For Ocular Melanoma Liver Metastases. |
|
|
Oct 12, 2016 |
1107 |
| United States : New Retrospective Analyses Confirm Vectibix (Panitumumab) Treatment Provided Survival Benefit Over Chemotherapy With Or Without Bevacizumab In Metastatic Colorectal Cancer Patients With Tumors Of Left-Sided Origin. |
|
|
Oct 12, 2016 |
463 |
| Final Results of NAPOLI-1 Study Confirm Overall Survival and Progression-Free Survival Benefit for the ONIVYDE Regimen for Patients with Metastatic Pancreatic Cancer. |
|
|
Oct 11, 2016 |
3602 |
| Delcath Announces New U.S. Clinical Sites For FOCUS Phase 3 Trial For Ocular Melanoma Liver Metastases. |
|
|
Oct 11, 2016 |
1072 |
| New Retrospective Analyses Confirm Vectibix (Panitumumab) Treatment Provided Survival Benefit Over Chemotherapy With Or Without Bevacizumab In Metastatic Colorectal Cancer Patients With Tumors Of Left-Sided Origin. |
|
|
Oct 10, 2016 |
6073 |
| United States : Opdivo (nivolumab) stabilized patient-reported outcomes in patients with previously treated recurrent or metastatic squamous cell carcinoma of the head and neck in pivotal phase 3 checkmate. |
|
|
Oct 10, 2016 |
398 |
| Phase III nintedanib trial results in patients with metastatic colorectal cancer announced at ESMO. |
|
|
Oct 9, 2016 |
1066 |
| STEM-BCPC: Signal Transduction and Epigenetic Mechanisms of Breast Cell Plasticity and Cancer. |
|
|
Oct 7, 2016 |
401 |
| Breast cancer metastasis to the thyroid gland. |
Goldenberg, Michael; Warrick, Joshua; Russo, Mariano; Bann, Darrin V. |
Report |
Oct 1, 2016 |
578 |
| Melanoma to the heart. |
Durham, Charis G.; Hall, James A.; Fidone, Erica J.; Mack, Ryan; Metting, Austin L. |
Clinical report |
Oct 1, 2016 |
1036 |
| The Prospective MOSCATO 01 Trial Demonstrates that Molecular "Portraits" Improve Outcome of Patients with Metastatic Cancer. |
|
|
Sep 22, 2016 |
819 |
| The Prospective MOSCATO 01 Trial Demonstrates that Molecular "Portraits" Improve Outcome of Patients with Metastatic Cancer. |
|
|
Sep 22, 2016 |
824 |
| Novartis survey published in The Breast Journal reveals major gaps in treatment discussions between metastatic breast cancer patients and doctors. |
|
|
Sep 14, 2016 |
1698 |
| Eisai Bewildered as German Institute for Quality and Efficiency in Health Care (IQWIG) Fails to Recognise Additional Benefit of Halaven (eribulin) in the Treatment of Advanced Liposarcoma. |
|
|
Sep 4, 2016 |
1949 |
| Merck and Pfizer have initiated a Phase III study, JAVELIN Ovarian 100, to evaluate the efficacy and safety of avelumab in combination with, and/or as follow-on (maintenance) treatment to, platinum-based chemotherapy in patients with locally advanced or metastatic disease (Stage III or Stage IV) with previously untreated epithelial ovarian cancer. |
|
|
Sep 1, 2016 |
189 |
| Initial response of renal cell carcinoma to vemurafenib in a patient treated for metastatic melanoma. |
Hosier, Gregory W.; Roberts, Matthew T. |
|
Sep 1, 2016 |
1726 |
| Adrenalectomy for solitary metastasis of Hepatocellular carcinoma post liver transplantation: Case report and literature review. |
|
|
Aug 31, 2016 |
1757 |
| OncoGenex Announces Results from the Phase 3 AFFINITY Trial of Custirsen in Men with Metastatic Castrate-Resistant Prostate Cancer. |
|
Financial report |
Aug 16, 2016 |
1250 |
| Switzerland : Novartis CDK4/6 inhibitor LEE011 (ribociclib) receives FDA Breakthrough Therapy designation as first-line treatment for HR+/HER2- advanced breast cancer. |
|
|
Aug 5, 2016 |
441 |
| Vitamin C induces regression of pulmonary metastases. |
Gaby, Alan R. |
Brief article |
Aug 1, 2016 |
240 |
| Circulating tumor cells: the root cause of cancer spreading. |
Connealy, Leigh Erin |
|
Aug 1, 2016 |
2302 |
| Perforation of gastric cancer--what should the surgeon do? |
Ignjatovic, Nebojsa; Stojanov, Dragan; Djordjevic, Miodrag; Ignjatovic, Jelena; Stojanov, Daniela Be |
|
Aug 1, 2016 |
3428 |
| Strategies to alleviate anxiety before the placement of a stereotactic radiosurgery frame. |
Avbovbo, Ufuoma E.; Appel, Susan J. |
Report |
Aug 1, 2016 |
3122 |
| Diagnostic Performance of Urinary EGFR Testing in Lung Cancer Patients Published in Journal of Thoracic Oncology. |
|
|
Jul 26, 2016 |
1489 |
| ONIVYDE Receives Positive CHMP Opinion for Treatment of Patients with Metastatic Adenocarcinoma of the Pancreas Who Have Progressed Following Gemcitabine Based Therapy. |
|
|
Jul 25, 2016 |
2531 |
| ONIVYDE Receives Positive CHMP Opinion for Treatment of Patients with Metastatic Adenocarcinoma of the Pancreas Who Have Progressed Following Gemcitabine Based Therapy. |
|
|
Jul 25, 2016 |
2526 |
| Outcomes Study On Delcath's Melphalan/HDS In The Treatment Of Hepatic Metastases To Be Published In Cancer Control. |
|
|
Jul 7, 2016 |
967 |
| Elsevier Launches PracticeUpdate Metastatic Breast Cancer Center of Excellence. |
|
|
Jul 6, 2016 |
712 |
| Elsevier Launches PracticeUpdate Metastatic Breast Cancer Center of Excellence. |
|
|
Jul 6, 2016 |
716 |
| Germany : Results of Pivotal TAILOR Study Confirm Addition of Erbitux to FOLFOX Significantly Improves Outcomes in RAS Wild-Type Metastatic Colorectal Cancer. |
|
Clinical report |
Jul 2, 2016 |
556 |
| Results of Pivotal TAILOR Study Confirm Addition of Erbitux to FOLFOX Significantly Improves Outcomes in RAS Wild-Type Metastatic Colorectal Cancer. |
|
Clinical report |
Jul 1, 2016 |
1788 |
| Patients with Colorectal Cancer Liver Metastases Had Significantly Greater Depth of Tumour Response to SIR-Spheres Y-90 resin microspheres, New SIRFLOX Analysis Shows. |
|
|
Jul 1, 2016 |
2020 |
| Patients with Colorectal Cancer Liver Metastases Had Significantly Greater Depth of Tumour Response to SIR-Spheres Y-90 resin microspheres, New SIRFLOX Analysis Shows. |
|
|
Jul 1, 2016 |
2026 |
| Results of Pivotal TAILOR Study Confirm Addition of Erbitux to FOLFOX Significantly Improves Outcomes in RAS Wild-Type Metastatic Colorectal Cancer. |
|
Clinical report |
Jul 1, 2016 |
1792 |
| Targeted therapy and immunotherapy may benefit patients with leptomeningeal metastases from melanoma. |
Shepphird, Jennifer |
|
Jul 1, 2016 |
454 |
| Can lymphovascular invasion replace the prognostic value of lymph node involvement in patients with upper tract urothelial carcinoma after radical nephroureterectomy? |
Yoo, Eun Sang; Ha, Yun-Sok; Lee, Jun Nyung; Kim, Bum Soo; Kim, Bup Wan; Byun, Seok-Soo; Choi, Young |
Clinical report |
Jul 1, 2016 |
5380 |
| Chemotherapy research for metastatic prostate cancer. |
Kapoor, Anil; Hotte, Sebastien J. |
Report |
Jul 1, 2016 |
3137 |
| Radionuclides. |
Kapoor, Anil; Hotte, Sebastien J. |
Report |
Jul 1, 2016 |
1417 |
| NAPOLI-1 Data Demonstrates ONIVYDE Regimen Maintains Quality of Life While Improving Overall Survival in Patients with Metastatic Pancreatic Cancer. |
|
|
Jun 30, 2016 |
3210 |
| United States : Updated Findings from KEYNOTE-012 for KEYTRUDA (pembrolizumab) Show Continued Benefit in Response Rates and Duration of Response Lasting Up to 30 Months in Patients with Previously Treated Recurrent or Metastatic Head and Neck Cancer. |
|
|
Jun 8, 2016 |
932 |
| United States : Pivotal Avelumab Study shows Positive Results in Metastatic Merkel Cell Carcinoma. |
|
|
Jun 7, 2016 |
659 |
| Final Analysis of First-in-Human Phase 1 Study of MM-151 Shows Positive Clinical Activity in Multiple Solid Tumor Types, Including Colorectal Cancer. |
|
|
Jun 6, 2016 |
1632 |
| First prospective clinical utility trial using comprehensive liquid biopsy to guide metastatic cancer patients to molecularly matched therapies demonstrates comparable results to tissue-based testing. |
|
|
Jun 6, 2016 |
689 |
| Mutated Gene Influencing Metastatic Colorectal Cancer Survival Rate, According to PiscoMed's Journal AMOR. |
|
|
Jun 3, 2016 |
822 |
| Malignant transformation of a high-grade osteoblastoma of the petrous apex with subcutaneous metastasis. |
Kraft, Casey T.; Morrison, Robert J.; Arts, H. Alexander |
Clinical report |
Jun 1, 2016 |
2207 |
| Pelvic limb amputation for the treatment of a soft-tissue sarcoma of the tibiotarso-tarsometatarsal joint in a blue-and-gold macaw (Ara ararauna). |
Summa, Noemie; Boston, Sarah; Eshar, David; Lee-Chow, Bridget; Harrison, Erin; Fischer, Catherine; J |
Report |
Jun 1, 2016 |
3538 |
| AstraZeneca to offer treatment options to postmenopausal women with HR+ locally-advanced or metastatic breast cancer upon successful Phase III FALCON trial. |
|
|
May 30, 2016 |
300 |
| AstraZeneca to offer treatment options to postmenopausal women with HR+ locally-advanced or metastatic breast cancer upon successful Phase III FALCON trial. |
|
|
May 30, 2016 |
296 |
| Merrimack and Baxalta Announce Initiation of Phase 1 Study of MM-151 in Combination with the ONIVYDE (irinotecan liposome injection) Regimen in Metastatic Colorectal Cancer. |
|
|
May 19, 2016 |
1477 |
| Decipher Prostate Cancer Test Guides Timing of Postoperative Radiotherapy. |
|
|
May 19, 2016 |
1243 |
| PDA_TGFb: TGF-beta mediated crosstalk between cancer (stem) cells and tumor microenvironment in pancreatic cancer metastasis. |
|
|
May 12, 2016 |
371 |
| People in Sweden, Denmark and Finland with Advanced Liposarcoma Now Able to Access Halaven (Eribulin), First-ever Treatment to Prolong Overall Survival in Rare and Aggressive Cancer. |
|
|
May 9, 2016 |
1557 |
| Hutchison China MediTech has initiated an open-label Phase II trial to evaluate the efficacy and safety of sulfatinib (HMPL-012) in patients with locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer (DTC). |
|
|
May 1, 2016 |
159 |
| Retrospective audit: does prior assessment by oral and maxillofacial surgeons reduce the risk of osteonecrosis of the jaw in patients receiving bone-targeted therapies for metastatic cancers to the skeleton?--Part II. |
Turner, Bruce; Ali, Sacha; Pati, Jhumur; Nargund, Vinod; Ali, Enamul; Cheng, Leo; Wells, Paula |
Report |
May 1, 2016 |
4029 |
| Impact of Cytoreductive Nephrectomy on Survival in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy. |
Song, Yan; Du, Chun-Xia; Zhang, Wen; Sun, Yong-Kun; Yang, Lin; Cui, Cheng-Xu; Chi, Yihe-Bali; Shou, |
Report |
May 1, 2016 |
3152 |
| Renal cell carcinoma extending to the inferior vena cava: a single center surgical experience. |
Sayyad, Ahmed J. Al; Algarni, Kamal S.; Jabbad, Husain H. |
Report |
May 1, 2016 |
2409 |
| Sentinel lymph node identification by blue dye in patients with breast carcinoma. |
|
|
Apr 30, 2016 |
2671 |
| Patients with Advanced Metastatic Colorectal Cancer in Europe Now Have New Treatment Option as LONSURF (R) (trifluridine/tipiracil) Receives EU Approval. |
|
|
Apr 28, 2016 |
2275 |
| Phase III TAILOR Landmark Study Demonstrates Significant Benefits of Erbitux in Combination with FOLFOX Over FOLFOX Alone. |
|
|
Apr 25, 2016 |
1585 |
| Phase III TAILOR Landmark Study Demonstrates Significant Benefits of Erbitux in Combination with FOLFOX Over FOLFOX Alone. |
|
|
Apr 25, 2016 |
1633 |
| The study of cutaneous manifestations of malignant diseases. |
Sangameshwara, G.M.; Venkatesh, U.; Indudhara P.B.; Ganga, H.; Lohith, S. |
Report |
Apr 25, 2016 |
1809 |
| Merck passes conditional approval for KEYTRUDA for the treatment of metastatic non-small cell lung cancer (NSCLC) in Canada. |
|
|
Apr 21, 2016 |
360 |
| Merck passes conditional approval for KEYTRUDA for the treatment of metastatic non-small cell lung cancer (NSCLC) in Canada. |
|
|
Apr 21, 2016 |
356 |
| United States : More Than Three Percent of Men on Active Surveillance for Prostate Cancer May Have Metastases. |
|
|
Apr 12, 2016 |
664 |
| Merck and Sysmex Inostics Receive CE Mark Approval for Liquid Biopsy Test for Colorectal Cancer Patients. |
|
|
Apr 7, 2016 |
1783 |
| Merck and Sysmex Inostics Receive CE Mark Approval for Liquid Biopsy test for Colorectal Cancer Patients. |
|
|
Apr 6, 2016 |
1787 |
| New Liquid Biopsy RAS Testing for Metastatic Colorectal Cancer Patients Now Available for Clinical Practices. |
|
|
Apr 6, 2016 |
1653 |
| New Liquid Biopsy RAS Testing for Metastatic Colorectal Cancer Patients Now Available for Clinical Practices. |
|
|
Apr 6, 2016 |
1659 |
| Halaven (Eribulin) Receives Positive CHMP Opinion in Advanced Liposarcoma Following Significant Phase III Data. |
|
|
Apr 3, 2016 |
1969 |
| Taiho's TAS-102 Meets Primary Endpoint of Improving Overall Survival in Phase III TERRA Study in Asian Patients with Refractory Metastatic Colorectal Cancer. |
|
Report |
Apr 1, 2016 |
1834 |
| United States : Tagrisso (osimertinib) approved in Japan for patients with EGFR T790M mutation-positive metastatic non-small cell lung cancer. |
|
|
Mar 30, 2016 |
496 |
| United States : XALKORI Approved by U.S. FDA for the Treatment of Patients with ROS1-Positive Metastatic Non-Small Cell Lung Cancer. |
|
|
Mar 14, 2016 |
514 |
| A simple prognostic model for overall survival in metastatic renal cell carcinoma. |
Assi, Hazem I.; Patenaude, Francois; Toumishey, Ethan; Ross, Laura; Abdelsalam, Mahmoud; Reiman, Ton |
Clinical report |
Mar 1, 2016 |
4738 |
| Efficacy, quality of life, and safety of cabazitaxel in Canadian metastatic castration-resistant prostate cancer patients treated or not with prior abiraterone. |
Saad, Fred; Winquist, Eric; Hubay, Stacey; Berry, Scott; Assi, Hazem; Levesque, Eric; Aucoin, Nathal |
Clinical report |
Mar 1, 2016 |
6460 |
| Clinical significance of circulating tumor microemboli as a prognostic marker in patients with pancreatic ductal adenocarcinoma. |
Chang, Ming-Chu; Chang, Yu-Ting; Chen, Jia-Yang; Jeng, Yung-Ming; Yang, Ching-Yao; Tien, Yu-Wen; Yan |
Report |
Mar 1, 2016 |
6256 |
| Malignant melanoma of the oral cavity. |
Vishnu, Prasad K.P.; Kamath, Panduranga Mulky; Shenoy, Vijendra; Rao, Raghavendra; Jayakrishna, Anne |
|
Feb 29, 2016 |
1581 |
| CHMP Issues Positive Opinion for LONSURF(R) (trifluridine/tipiracil) for Refractory Metastatic Colorectal Cancer. |
|
|
Feb 29, 2016 |
1865 |
| United Kingdom : TAGRISSO (osimertinib) approved in EU as first-in-class treatment for patients with EGFR T790M mutation-positive metastatic non-small cell lung cancer. |
|
|
Feb 4, 2016 |
659 |
| United States : Lynparza (olaparib) granted Breakthrough Therapy designation by US FDA for treatment of BRCA1/2 or ATM gene mutated metastatic Castration Resistant Prostate Cancer. |
|
|
Jan 29, 2016 |
455 |
| Vectibix (panitumumab) And Best Supportive Care Improves Overall Survival Compared To Best Supportive Care In Chemorefractory KRAS And RAS Wild-Type Metastatic Colorectal Cancer. |
|
|
Jan 23, 2016 |
3777 |
| OncoGenex Announces Update on Phase 2 Spruce Trial in Previously Untreated Metastatic Non-Small Cell Lung Cancer. |
|
|
Jan 20, 2016 |
1072 |
| Updated Data Shows ONIVYDE (irinotecan liposome injection) Combination Regimen Increased One Year Survival by 63% in Patients with Metastatic Pancreatic Cancer. |
|
|
Jan 19, 2016 |
3544 |
| Surgical management of bulky mediastinal metastases in follicular thyroid carcinoma. |
Adwin, Zainal; Nur, Ayub; Suhaimi, Shahrun; Rahman, Ramzisham |
Report |
Jan 1, 2016 |
1263 |
| Disseminated Kaposi sarcoma with osseous metastases in an HIV-positive patient. |
Bell, Bruce M., Jr.; Syed, Almas; Carmack, Susanne W.; Thomas, Cody A.; Layton, Kennith F. |
Clinical report |
Jan 1, 2016 |
1092 |
| Metastatic thymoma involving the bone marrow. |
Dekmezian, Mhair; Wenceslao, Stella; Krause, John R. |
Clinical report |
Jan 1, 2016 |
1792 |
| Merck KGaA, Darmstadt, Germany, and Pfizer have received Breakthrough Therapy designation for avelumab for the treatment of patients with metastatic Merkel cell carcinoma (MCC) who have progressed after at least one previous chemotherapy regimen. |
|
|
Jan 1, 2016 |
168 |
| Skeletal health Part 1: overview of bone health and management in the cancer setting. |
Turner, Bruce; Ali, Sucha; Drudge-Coates, Lawrence; Pati, Jhumur; Nargund, Vinod; Wells, Paula |
Report |
Jan 1, 2016 |
4800 |
| Skeletal health Part 2: development of a nurse practitioner bone support clinic for urologic patients. |
Turner, Bruce; Ali, Sacha; Drudge-Coates, Lawrence; Pati, Jhumur; Nargund, Vinod; Wells, Paula |
Report |
Jan 1, 2016 |
2830 |
| Port-site metastasis after laparoscopic subtotal gastrectomy in gastric cancer: An uncommon case report. |
Yang, Chien-Yi; Chan, De-Chuan; Yu, Jyh-Cherng; Lu, Huai-En |
|
Jan 1, 2016 |
1429 |
| Histopathological analysis and surgical treatment of breast cancer--our experience/Histopatoloska analiza ihirurski tretman raka dojke--nase iskustvo. |
Detanac, Dzemail S.; Detanac, Dzenana A.; Ceranic, Avdo; Ceranic, Merima A. |
Report |
Jan 1, 2016 |
3176 |
| The predictive factors for lymph node metastasis in early gastric cancer: A clinical study. |
|
Clinical report |
Dec 31, 2015 |
2807 |
| INSIGHTEC Announces Continued Success in Securing Positive Coverage Policies Within the Blue Cross Blue Shield Family of Companies for MRgFUS Treatments of Pain Palliation for Bone Metastases. |
|
|
Dec 22, 2015 |
528 |
| United States : TAGRISSO (osimertinib) receives positive CHMP opinion for patients with EGFR T790M mutation-positive metastatic non-small cell lung cancer. |
|
|
Dec 19, 2015 |
553 |
| Scientists Gain Better Understanding of How Dormant Circulating Tumor Cells in Breast Cancer Become Metastatic in the Brain. |
|
|
Dec 16, 2015 |
936 |
| Rare but there: male breast cancer. |
Nagarkar, Raj.; Roy, Sirshendu; Adhav, Aditya; Jadhav, Abhishek; Tondare, Ashutosh |
|
Dec 14, 2015 |
1639 |
| Tumefactive multiple sclerosis masquerading as cancer. |
Khan, Kamran; Wozniak, Susan E.; Coleman, JoAnn |
|
Dec 1, 2015 |
1745 |
| A study of the recurrence rates in patients with carcinoma anorectum undergoing abdominoperineal resection. |
Gill, Hardeep Singh; Jain, Puneet; Singh, Anantbir; Jain, Satish |
Clinical report |
Nov 23, 2015 |
6218 |
| Germany : Merck and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma. |
|
|
Nov 19, 2015 |
481 |
| Germany,United States : Merck KGaA, Darmstadt, Germany, and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma. |
|
|
Nov 19, 2015 |
491 |
| CYTOPRO: Profiling of tumour cells in blood for personalized treatment of metastatic cancer. |
|
|
Oct 26, 2015 |
381 |
| Burden of illness of bone metastases in prostate cancer patients in Quebec, Canada: a population-based analysis. |
Perrault, Louise; Fradet, Vincent; Lauzon, Veronique; LeLorier, Jacques; Mitchell, Dominic; Habib, M |
|
Oct 1, 2015 |
5920 |
| Cytotoxic and Genotoxic biomonitering in patients exposed to radiation therapy a cytological study. |
Sushma, Susik M.; Shyam, Prasad Reddy D.; Keerthi, M. |
Report |
Oct 1, 2015 |
1784 |
| Trocar site metastasis following robotic oophorectomy for ovarian cancer: a case report and review of the literature. |
Gauthier, Jason M.; Hauch, Adam; Duong, Buu T.; Crawford, Byron E.; Robinson, William R.; Kandil, Em |
Clinical report |
Sep 1, 2015 |
1730 |
| Comparison of Therapeutic Efficacy between Gastrectomy with Transarterial Chemoembolization Plus Systemic Chemotherapy and Systemic Chemotherapy Alone in Gastric Cancer with Synchronous Liver Metastasis. |
Liu, Sen-Feng; Lu, Can-Rong; Cheng, Hai-Dong; Xi, Hong-Qing; Cui, Jian-Xin; Li, Ji-Yang; Shen, Wei-S |
Report |
Aug 20, 2015 |
3951 |
| Diplomat to introduce IRESSA as a first-line treatment for selected patients with metastatic non-small cell lung cancer. |
|
|
Aug 11, 2015 |
261 |
| Diplomat to introduce IRESSA as a first-line treatment for selected patients with metastatic non-small cell lung cancer. |
|
|
Aug 11, 2015 |
257 |
| Celsion and myTomorrows Expand ThermoDox European Early Access Program to Include Patients with Primary Liver Cancer and Liver Cancer Metastases. |
|
|
Aug 10, 2015 |
1196 |
| Metastatic Cancer Research Studies Should Better Evaluate and Communicate Quality of Life Measures. |
|
|
Aug 6, 2015 |
560 |
| Bone metastases affect prognosis but not effectiveness of third-line targeted therapies in patients with metastatic renal cell carcinoma. |
Iacovelli, Roberto; Santini, Daniele; Rizzo, Mimma; Felici, Alessandra; Santoni, Matteo; Verzoni, El |
Report |
Aug 1, 2015 |
3478 |
| Metastatic renal cell cancer: summary from ASCO 2015. |
|
Conference notes |
Aug 1, 2015 |
2447 |
| Third-line treatment in metastatic renal cell carcinoma and bone metastases. |
Heng, Daniel Y.C. |
Viewpoint essay |
Aug 1, 2015 |
667 |
| Experimental Computed Tomography-guided Vena Cava Puncture in Pigs for Percutaneous Brachytherapy of Middle Mediastinal Lymph Node Metastases. |
Zhao, Min; Liu, Bin; Li, Sheng-Yong; Wang, Yong-Zheng; Li, Yu-Liang; Hertzanu, Yancu |
Report |
Aug 1, 2015 |
3040 |
| FDA Grants Breakthrough Therapy Designation to Eisai's Lenvatinib for the Potential Treatment of Metastatic Renal Cell Carcinoma. |
|
|
Jul 28, 2015 |
2024 |
| INSIGHTEC Announces That Blue Cross Blue Shield (BCBS) Have Approved Additional Positive Coverage Policies for MRgFUS Treatments of Pain Palliation for Bone Metastases in 18 U.S. States. |
|
|
Jul 16, 2015 |
541 |
| Elbit Imaging Ltd. Announces That InSightec Announces that Additional BCBS Plans Have Published Positive Coverage Policies for MRgFUS Treatments in the Treatment of Pain Palliation for Bone Metastases. |
|
|
Jul 14, 2015 |
702 |
| miROMeS: miRNA biomarkers of Osseous Metastases in Serum from breast cancer patients. |
|
|
Jul 1, 2015 |
322 |
| CAPTURE-CTC: A Streptavidin Microarray Platform for Capturing of Circulating Tumor Cells from the Blood of Cancer Patients. |
|
|
Jun 29, 2015 |
369 |
| Clinical Care Options Releases Report on Critical Practice Gaps in Care of Metastatic Breast Cancer. |
|
|
Jun 22, 2015 |
777 |
| Results From Phase 3 Trial Show Vectibix (Panitumumab) Improves Overall Survival In Chemorefractory Wild-Type KRAS Metastatic Colorectal Cancer Versus Best Supportive Care. |
|
|
Jun 18, 2015 |
3245 |
| Clinical Experts Report on How Varian Technology Can Be Used for the Precise, Noninvasive, Simultaneous Treatment of Multiple Metastases in the Brain, Spine, Head & Neck, and Lung. |
|
|
Jun 9, 2015 |
987 |
| The action of hyperthermia in metastatic colorectal cancer in combination with chemotherapy. |
Mandraveli, E.; Theodosopoulou, E.; Pistofidis, A.; Alexandratou, K.; Alexandratos, A.; Xatzopoulou, |
Report |
Jun 1, 2015 |
6616 |
| Port site metastasis in prostate cancer. |
De Bruyne, Peter; Schatteman, Peter; De Naeyer, Geert; Carpentier, Paul; Mottrie, Alex |
Clinical report |
Jun 1, 2015 |
1641 |
| Combination of Novartis drugs Tafinlar and Mekinist shows significant survival benefit in patients with metastatic melanoma. |
|
|
May 31, 2015 |
3066 |
| Halozyme Phase 2 Clinical Study Of Investigational Drug PEGPH20 Shows Doubling Of Progression-free Survival And Improvement Trend In Overall Survival In High HA Metastatic Pancreatic Cancer Patients. |
|
Clinical report |
May 31, 2015 |
1433 |
| PharmaEngine Announces Filing New Drug Application (NDA) of MM-398 (PEP02) to Taiwan FDA as a Treatment for Post-Gemcitabine Metastatic Pancreatic Cancer. |
|
|
May 31, 2015 |
725 |
| PROCLAIM(SM) Patient Registry Data Demonstrates Safety and Efficacy of Proleukin (aldesleukin) When Sequenced with Immune Checkpoint Inhibitors in Metastatic Melanoma. |
|
|
May 28, 2015 |
1638 |
| PROCLAIM Patient Registry Data Demonstrate Survival Benefit of First-line Proleukin Therapy in Patients with Metastatic Renal Cell Carcinoma. |
|
|
May 28, 2015 |
1468 |
| Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma. |
|
Clinical report |
May 26, 2015 |
2265 |
| New Data Show Proleukin (aldesleukin) Improves Patient Outcomes as First-Line Therapy for the Treatment of Patients with Metastatic Melanoma or Metastatic Renal Cell Carcinoma. |
|
Clinical report |
May 15, 2015 |
1526 |
| Differential proteomic analysis on the effects of 2-methoxy-1,4-naphthoquinone towards MDA-MB-231 cell line. |
Liew, Kitson; Yong, Phelim Voon Chen; Navaratnam, Visweswaran; Lim, Yang Mooi; Ho, Anthony Siong Hoc |
Report |
May 15, 2015 |
9848 |
| New Data from IMAGE 1 Show Improved Survival in Metastatic Pancreatic Cancer in Patients Receiving IMM-101. |
|
Clinical report |
May 14, 2015 |
835 |
| Volumetric assessment of lymph node metastases in patients with non-seminomatous germ cell tumours treated with chemotherapy. |
Basilio-de-Leo, Carlos I.; Villeda-Sandoval, Christian I.; Culebro-Garcia, Carolina; Rodriguez-Covar |
Report |
May 1, 2015 |
3411 |
| Cryoport Supports NeoStem's Intus Study for the Treatment of Metastatic Melanoma. |
|
|
Apr 29, 2015 |
968 |
| Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer. |
|
|
Apr 20, 2015 |
1490 |
| Elbit Imaging Ltd. Announces That Insightec Announces BCBS North Carolina and Horizon BCBS of New Jersey Published Positive Coverage of MRgFUS Treatments for Pain Palliation of Bone Cancer Metastases. |
|
|
Apr 16, 2015 |
678 |
| European Commission Approves Amgen's Vectibix (panitumumab) As First-Line Treatment In Combination With FOLFIRI Chemotherapy For Metastatic Colorectal Cancer. |
|
|
Apr 6, 2015 |
2497 |
| Rare case of colonic metastasis. |
Vinod, Kumar B.; Gatty, Rohan C.; Matthias, Sheldon G.; Martis, John Joseph S. |
Clinical report |
Apr 2, 2015 |
799 |
| Biomarker Testing Before First Line Therapy Key to Improving Survival Rates for Patients Newly Diagnosed With Metastatic Colorectal Cancer. |
|
|
Mar 24, 2015 |
1385 |
| Thyroid malignancies: a prospective study in a rural teaching Medical College Hospital. |
Anantharamakrishnan, R.; Kumar, K. Senthil |
|
Mar 9, 2015 |
2376 |
| Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options. |
|
|
Feb 26, 2015 |
1364 |
| Cancer pain management: role of intrathecal alcohol: a case report. |
Singh, K. Upendra; Singh, Kh. Lokeshwar; Singh, S. Thoibahenba; Charan, N.; Kay, Jonan Puni |
|
Feb 16, 2015 |
1534 |
| Amgen Announces FDA Advisory Committees To Review Talimogene Laherparepvec For The Treatment Of Patients With Metastatic Melanoma. |
|
|
Feb 11, 2015 |
2024 |
| Palliative endoscopic surgery for sinonasal metastases: a case report and literature review. |
Roberts, Jason M.; Brook, Christopher; Parnes, Steven |
Brief article |
Feb 1, 2015 |
117 |
| Basaloid squamous cell carcinoma of the sinonasal tract with metastasis to the liver: a case report and literature review. |
Toe, Boon Ping; Ramli, Norlisah; Lam, Sze Yin; Wong, Kum Thong; Prepageran, Narayanan |
Case study |
Feb 1, 2015 |
184 |
| An unusual case of penile metastases from Osteosarcoma of femur. |
Kamoji, Sushruth G.; Arunkumar, S.; Shariff, V.N.S. Ahamed |
Clinical report |
Jan 12, 2015 |
1128 |
| Metastatic pancreatic neuroendocrine tumor with ectopic adrenocorticotropic hormone production. |
Vaduganathan, Muthiah; Nagarur, Amulya; Kerr, Darcy A.; Lauter, Kelly B.; Padmanabhan, Arun; Raghava |
Report |
Jan 1, 2015 |
2444 |
| Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery. |
|
|
Dec 22, 2014 |
917 |
| Halaven (Eribulin) in Combination with Capecitabine Provides Clinical Benefit for Women with Metastatic Breast Cancer. |
|
|
Dec 9, 2014 |
2687 |
| Evaluation of second-line and subsequent targeted therapies in metastatic renal cell cancer (mRCC) patients treated with first-line cediranib. |
Richter, Suzanne; Seah, Jo-An; Pond, Gregory R.; Gan, Hui K.; Mackenzie, Mary J.; Hotte, Sebastien J |
Report |
Dec 1, 2014 |
3357 |
| InSightec Invites RSNA 2014 Attendees to Learn About its MR-Guided Focused Ultrasound Solution for Treatment of Uterine Fibroids and Alleviation of Pain Caused by Bone Metastases. |
|
|
Nov 25, 2014 |
544 |
| Zytiga is Currently the Most Commonly Prescribed Second-Line Therapy for Metastatic Castrate-Resistant Prostate Cancer, According to Surveyed European Oncologists. |
|
|
Nov 18, 2014 |
728 |
| Prognostic factors for overall survival with targeted therapy in Chinese patients with metastatic renal cell carcinoma. |
Zhao, Juping; Huang, Xin; Sun, Fukang; Ma, Renyi; Wang, Haofei; Shao, Kun; Zhu, Yu; Zhou, Wenlong; X |
Report |
Nov 1, 2014 |
4856 |
| Circulating tumor cells provide genomic snapshot of breast cancer. |
|
Brief article |
Nov 1, 2014 |
242 |
| Ante-grade intramedullary nailing for the treatment of humeral shaft metastatic bone tumor. |
Chen, Jiang-Long; Yeh, Tsu-Te; Pan, Ru-Yu; Wu, Chia-Chun |
Report |
Nov 1, 2014 |
2541 |
| United Kingdom : Xtandi (Enzalutamide) capsules receive positive CHMP opinion for the treatment of men with metastatic castration-resistant prostate cancer who are chemotherapy-naive. |
|
|
Oct 28, 2014 |
295 |
| CyberKnife Treatment Helps Metastatic Breast Cancer Patient. |
|
|
Oct 21, 2014 |
574 |
| Evaluation of gall bladder carcinoma by ultrasonography and computed tomography & its comparison: A study of 50 cases. |
Deka, Nabanita; Goswami, Gautam; Hazarika, Manoj; Bharati, Ashok |
|
Oct 9, 2014 |
2849 |
| InSightec Announces HCSC Positive Coverage Decision for its MRgFUS Procedure for Pain Palliation of Bone Cancer Metastases. |
|
|
Oct 6, 2014 |
555 |
| Elbit Imaging Ltd. Announces That InSightec Announces HCSC Positive Coverage Decision For Its ExAblate Procedure For Pain Palliation Of Bone Cancer Metastases. |
|
|
Oct 5, 2014 |
687 |
| United Kingdom : GSK announces overall survival results from phase III BREAK-3 study of Tafinlar(dabrafenib) in patients with BRAF V600E-mutant metastatic melanoma. |
|
Clinical report |
Sep 30, 2014 |
447 |
| RENAL CELL CARCINOMA METASTASIZING TO PAROTID GLAND. |
|
Report |
Sep 30, 2014 |
1444 |
| SIR-Spheres Y-90 Resin Microspheres Recommended in New European Society of Medical Oncology (ESMO) Clinical Guidelines for Treating Metastatic Colorectal Cancer (mCRC). |
|
|
Sep 29, 2014 |
811 |
| SIR-Spheres y-90 Resin Microspheres Recommended in New European Society of Medical Oncology (ESMO) Clinical Guidelines for Treating Metastatic Colorectal Cancer (mCRC). |
|
|
Sep 29, 2014 |
892 |
| Bayer and Orion Initiate Phase III Trial of ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer. |
|
|
Sep 16, 2014 |
784 |
| Eli Lilly and Company's ramucirumab meets primary endpoint of overall survival in metastatic colorectal cancer patients. |
|
Clinical report |
Sep 15, 2014 |
235 |
| Eli Lilly and Company's ramucirumab meets primary endpoint of overall survival in metastatic colorectal cancer patients. |
|
Clinical report |
Sep 15, 2014 |
239 |
| Amgen submits talimogene laherparepvec's MAA for approval in the EU for treating metastatic melanoma. |
|
|
Sep 3, 2014 |
202 |
| Amgen submits talimogene laherparepvec's MAA for approval in the EU for treating metastatic melanoma. |
|
|
Sep 3, 2014 |
198 |
| Using molecular profiling diagnostics to identify predictive biomarkers in metastatic cancer. |
Van Tine, Brian A. |
Report |
Sep 1, 2014 |
1679 |
| A multicentre analysis of abiraterone acetate in Canadian patients with metastatic castration-resistant prostate cancer. |
Clayton, Ravinder; Wu, Jackson; Heng, Daniel Y.; North, Scott A.; Emmenegger, Urban; Hotte, Sebastie |
Report |
Sep 1, 2014 |
3507 |
| Study Shows that RapidArc Radiosurgery Substantially More Efficient and Comparable in Quality to Gamma Knife in the Treatment of Multiple Brain Metastases. |
|
|
Jul 30, 2014 |
1328 |
| In vivo and in vitro anti-tumor and anti-metastasis effects of Coriolus versicolor aqueous extract on mouse mammary 4T1 carcinoma. |
Luo, Ke-Wang; Yue, Grace Gar-Lee; Ko, Chun-Hay; Lee, Julia Kin-Ming; Gao, Si; Li, Long-Fei; Li, Gang |
Report |
Jul 15, 2014 |
6786 |
| Ossifying fibromyxoid tumor metastatic to the thyroid: a case report and review of the literature. |
Lastra, Ricardo R.; Newman, Jason G.; Brooks, John S.; Huang, Jui-Han |
Case study |
Jun 1, 2014 |
1660 |
| Amgen Highlights Phase 2 Results Of Vectibix (panitumumab) Versus bevacizumab In Combination With FOLFOX In Patients With Wild-Type RAS (KRAS And NRAS) Metastatic Colorectal Cancer. |
|
|
May 31, 2014 |
2354 |
| PROCLAIM(SM) National Patient Registry Analysis Shows Improved Median Overall Survival in Patients with Metastatic Melanoma Treated with High-Dose Interleukin-2 (HD IL-2). |
|
|
May 31, 2014 |
1551 |
| PROCLAIM(SM) Patient Registry Data Show Extension of Overall Survival Benefits Beyond Complete and Partial Responders in Metastatic Renal Cell Carcinoma Patients Treated with High-Dose Interleukin-2 (HD IL-2). |
|
|
May 30, 2014 |
1916 |
| Surveyed Oncologists Indicate Delayed Disease Progression is Among One of the Greatest Unmet Needs in First-Line Chemotherapy-Naive Metastatic Castrate-Resistant Prostate Cancer. |
|
|
May 28, 2014 |
669 |
| Studies Show that GenomeDx Biosciences' Decipher Test is a Better Predictor of Metastatic Prostate Cancer than Existing Tools. |
|
|
May 20, 2014 |
950 |
| Germany : Merck Announces New Retrospective Analysis Shows Significant Clinical Benefit in Overall Survival for Metastatic Colorectal Cancer Patients with RAS Wild-Type Tumors Receiving Erbitux plus F. |
|
|
May 17, 2014 |
264 |
| Merck Announces New Retrospective Analysis Shows Significant Clinical Benefit in Overall Survival for Metastatic Colorectal Cancer Patients with RAS Wild-Type Tumors Receiving Erbitux plus FOLFIRI. |
|
|
May 15, 2014 |
1704 |
| Taiho Oncology's TAS-102 Meets Primary Endpoint of Improving Overall Survival in Global Phase III RECOURSE Trial in Refractory Metastatic Colorectal Cancer. |
|
|
May 12, 2014 |
1091 |
| Taiho Oncology's TAS-102 Meets Primary Endpoint of Improving Overall Survival in Global Phase III RECOURSE Trial in Refractory Metastatic Colorectal Cancer. |
|
|
May 12, 2014 |
1084 |
| New Chemotherapy Combination Extends Survival For Metastatic Pancreatic Cancer By Nearly Two Months. |
|
|
May 1, 2014 |
762 |
| Cutaneous metastasis of colon cancer: case report and literature review. |
Sheets, Nicholas; Powers, Jeremy; Richmond, Bryan |
Clinical report |
May 1, 2014 |
1571 |
| Thought Leaders are Optimistic that Emerging Therapies will Offer Efficacy Benefits Over Current Therapies for Metastatic Gastric Cancer; Augmenting Biomarker-Driven Prescribing. |
|
|
Apr 10, 2014 |
553 |
| Cover the company%s genomic tests for breast cancer patients and patients with metastatic disease. |
|
|
Apr 10, 2014 |
126 |
| Amgen Provides Update On Phase 3 Study Of Talimogene Laherparepvec In Patients With Metastatic Melanoma. |
|
|
Apr 4, 2014 |
1866 |
| Astellas Announces European Regulatory Submission For XTANDI (enzalutamide) Capsules For Chemotherapy-Naive Metastatic Prostate Cancer. |
|
|
Apr 3, 2014 |
1256 |
| Germany : Bayer Initiates Phase III Trial of Radium-223 Dichloride in Combination with Abiraterone Acetate for Patients with Metastatic Castration-Resistant Prostate Cancer. |
|
|
Apr 3, 2014 |
425 |
| Taiho's Lonsurf(R) (trifluridine and tipiracil hydrochloride) Tablets Approved In Japan for Treatment of Advanced Metastatic Colorectal Cancer. |
|
|
Mar 24, 2014 |
576 |
| Taiho's Lonsurf (R) (trifluridine and tipiracil hydrochloride) Tablets Approved in Japan for Treatment of Advanced Metastatic Colorectal Cancer. |
|
|
Mar 24, 2014 |
573 |
| Germany : PTPSMETBC: Roles of SHP2 and other protein tyrosine phosphatases in metastatic breast cancer. |
|
|
Mar 18, 2014 |
363 |
| SWITZERLAND - Roles of SHP2 and other protein tyrosine phosphatases in metastatic breast cancer. (PTPSMETBC). |
|
|
Mar 3, 2014 |
362 |
| Molecular testing as a tool for the management of metastatic cancer patients. |
Cherkis, Karen Ann; Schroeder, Brock E. |
Report |
Mar 1, 2014 |
3592 |
| Primary testicular carcinoid tumour with mature teratoma in undescended testis metastatic to lymph nodes. |
Kim, Jae Heon; Noh, Tae Il; Shim, Ji Sung; Ham, Byeong Kuk; Choi, Hoon; Bae, Jae Hyun; Park, Jae You |
Clinical report |
Mar 1, 2014 |
1923 |
| Clinical outcomes in patients with metastatic renal cell carcinoma receiving everolimus or temsirolimus after sunitinib. |
Iacovelli, Roberto; Cartenì, Giacomo; Milella, Michele; Berardi, Rossana; Di Lorenzo, Giusep |
Report |
Mar 1, 2014 |
3029 |
| A rare case of testicular metastasis of bladder transitional cell carcinoma. |
Turo, Rafal; Smolski, Michal; Hatimy, Umi; Bromage, Stephen J.; Brown, Stephen C.W.; Brough, Richard |
Clinical report |
Mar 1, 2014 |
1308 |
| Eisai Announces Initiation of a Phase 3 Trial of Eribulin Mesylate Injection Versus Weekly Paclitaxel in First and Second Lines of Metastatic Breast Cancer. |
|
|
Feb 27, 2014 |
1485 |
| Independent Study Demonstrates Effectiveness of KivaSystem for Patients With Osteolytic Vertebral Metastases. |
|
Clinical report |
Feb 25, 2014 |
824 |
| Oncothyreon and Array BioPharma Announce Initiation of Phase 1b Trial of ONT-380 in Combination with TDM-1 in Patients with Metastatic HER2+ Breast Cancer. |
|
|
Feb 20, 2014 |
1482 |
| Bayer Initiates Phase III Trial of Stivarga (regorafenib) Tablets in Patients with Colorectal Cancer after Resection of Liver Metastases. |
|
|
Feb 20, 2014 |
2241 |
| Enzo Biochem's unit to distribute Nuclea's HER-2/neu serum test for metastatic breast cancer. |
|
|
Feb 19, 2014 |
166 |
| BioTheranostics launches panel of genomic-based tests for metastatic cancer. |
|
|
Feb 4, 2014 |
144 |
| Oncothyreon and Array BioPharma Announce Initiation of Phase 1b Trial of ONT-380 in Combination with Capecitabine and/or Trastuzumab in Patients with Metastatic HER2+ Breast Cancer. |
|
|
Feb 3, 2014 |
1618 |
| Etirinotecan Pegol (NKTR-102) Passes Interim Efficacy Analysis for BEACON Pivotal Phase 3 Clinical Study in Patients with Metastatic Breast Cancer. |
|
Clinical report |
Jan 14, 2014 |
2102 |
| Synta Pharmaceuticals Corp to start pan-European Study of ganetespib in p53 mutant, metastatic ovarian cancer patients. |
|
|
Jan 10, 2014 |
233 |
| Synta Pharmaceuticals Corp to start pan-European Study of ganetespib in p53 mutant, metastatic ovarian cancer patients. |
|
|
Jan 10, 2014 |
229 |
| Prognostic significance of metastasis-related microRNAs in early breast cancer patients with a long follow-up. |
Markou, Athina; Yousef, George M.; Stathopoulos, Efstathios; Georgoulias, Vassilis; Lianidou, Evi |
Report |
Jan 1, 2014 |
5563 |
| Prognostic relevance of viable circulating tumor cells detected by EPISPOT in metastatic breast cancer patients. |
Ramirez, Jean-Marie; Fehm, Tanja; Orsini, Mattea; Cayrefourcq, Laure; Maudelonde, Thierry; Pantel, K |
Report |
Jan 1, 2014 |
5333 |
| Carcinoma en cuirasse. |
|
Clinical report |
Dec 31, 2013 |
806 |
| European Commission Approves Update of Erbitux Metastatic Colorectal Cancer Labeling to Patients With RAS Wild-Type Tumors. |
|
|
Dec 23, 2013 |
1305 |
| European Commission Approves Update of Erbitux Metastatic Colorectal Cancer Labeling to Patients With RAS Wild-Type Tumors. |
|
|
Dec 23, 2013 |
1308 |
| At Twelve Months Post-Launch, the Majority of Surveyed Oncologists Have Prescribed Xtandi to Their Docetaxel-Pretreated Metastatic Castrate-Resistant Prostate Cancer Patients. |
|
|
Dec 9, 2013 |
708 |
| A phase I dose-escalation study of oral BR-DIM (bioresponse 3,3'- diindolylmethane) in castrate-resistant, non-metastatic prostate cancer. |
|
|
Dec 1, 2013 |
347 |
| Significance of circulating tumor cells detected by the CellSearch system in patients with metastatic breast colorectal and prostate cancer. |
|
|
Dec 1, 2013 |
144 |
| Celgenea[euro](tm)s ABRAXANE receives positive CHMP opinion in combination with Gemcitabine for treating metastatic pancreatic cancer. |
|
|
Nov 25, 2013 |
215 |
| Celgenea[euro](tm)s ABRAXANE receives positive CHMP opinion in combination with Gemcitabine for treating metastatic pancreatic cancer. |
|
|
Nov 25, 2013 |
219 |
| Merck Serono Announces CHMP Positive Opinion to Update Erbitux Metastatic Colorectal Cancer Labeling to Patients with RAS Wild-type Tumors. |
|
|
Nov 22, 2013 |
1232 |
